: The function of ILT4 blocking treatment on cell malignant phenotype and the expression of VEGF-C. A. Comparison of cell proliferation of A549 cells with or without ILT4 blocking antibody treatment by MTT assay. Comparison of B. and C. cell migration and D. and E. invasion of A549 cells with or without ILT4 blocking antibody by the invasion and migration assay, respectively. (Magnification × 400) The expression levels of VEGF-C in A549 cells with or without ILT4 blocking antibody treatment by F. PCR and G. Western blot analysis. The error bars indicate ± SEM. *P < 0.05; **P < 0.01 by Student's t-test. All the results were repeated thrice. Abbreviations: NSCLC, non-small cell lung cancer; TNM, tumor node metastasis.
Supplementary

Supplementary Table 2: Correlations of both ILT4 and VEGF-C co-expression with clinicopathological parameters in primary human NSCLC tissues
Variables ILT4+/VEGF-C+ ILT4+/VEGF-C-ILT4-/VEGF-C+ ILT4-/VEGF-C- Note: p 1, P value between ILT4+/VEGF-C+ and ILT4+/VEGF-C-; p 2, P value between ILT4+/VEGF-C+ and ILT4-/ VEGF-C+; p 3, P value between ILT4+/VEGF-C+ and ILT4-/VEGF-C-. Abbreviations: NSCLC, non-small cell lung cancer; TNM, tumor node metastasis.
